Cyanotech Corporation (OTC:CYAN)

Friday, August 10, 2012 | Web News
First Quarter 2013 Results Revenues were $6,506,000 compared to $5,950,000, an increase of 9%. Net income...
Thursday, June 21, 2012 | Web News
Fourth Quarter 2012 Results For the fourth quarter of fiscal 2012 compared to the fourth quarter of fiscal 2011, revenues were $5,986,000 compared...
Thursday, February 9, 2012 | Web News
Third Quarter 2012 Results For the third quarter of fiscal 2012 compared to the third quarter of fiscal 2011, revenues were $6,706,...
See All Research...
Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 54 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit http://www.cyanotech.com/for more information.

Web site: http://www.cyanotech.com

Last updated June 5, 2008


Market Data powered by QuoteMedia. Terms of Use